Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Nov;36(11):2468-2480.
doi: 10.1002/mds.28753. Epub 2021 Aug 25.

Genotype-Phenotype Relations in Primary Familial Brain Calcification: Systematic MDSGene Review

Alexander Balck  1   2 , Susen Schaake  1 , Neele Sophie Kuhnke  1 , Aloysius Domingo  1   3 , Harutyun Madoev  1 , Jason Margolesky  4 , Valerija Dobricic  1   5 , Daniel Alvarez-Fischer  1 , Björn-Hergen Laabs  6 , Meike Kasten  1   7 , Wei Luo  8 , Gael Nicolas  9 , Connie Marras  10 , Katja Lohmann  1 , Christine Klein  1 , Ana Westenberger  1
Affiliations
Review

Genotype-Phenotype Relations in Primary Familial Brain Calcification: Systematic MDSGene Review

Alexander Balck et al. Mov Disord. 2021 Nov.

Abstract

This systematic MDSGene review covers individuals with confirmed genetic forms of primary familial brain calcification (PFBC) available in the literature. Data on 516 (47% men) individuals, carrying heterozygous variants in SLC20A2 (solute carrier family 20 member 2, 61%), PDGFB (platelet-derived growth factor subunit B, 12%), XPR1 (xenotropic and polytropic retrovirus receptor, 16%), or PDGFRB (platelet-derived growth factor receptor beta, 5%) or biallelic variants in MYORG (myogenesis-regulating glycosidase, 13%) or JAM2 (junctional adhesion molecule 2, 2%), were extracted from 93 articles. Nearly one-third of the mutation carriers were clinically unaffected. Carriers of PDGFRB variants were more likely to be clinically unaffected (~54%), and the penetrance of SLC20A2 and XPR1 variants (<70%) was lower in comparison to the remaining three genes (>85%). Among the 349 clinically affected patients, 27% showed only motor and 31% only nonmotor symptoms/signs, whereas the remaining 42% had a combination thereof. While parkinsonism and speech disturbance were the most frequently reported motor manifestations, cognitive deficits, headache, and depression were the major nonmotor symptoms/signs. The basal ganglia were always calcified, and the cerebellum, thalamus, and white matter contained calcifications in 58%, 53%, and 43%, respectively, of individuals. In autosomal-dominant PFBC, mutation severity influenced the number of calcified brain areas, which in turn correlated with the clinical status, whereby the risk of developing symptoms/signs more than doubled for each additional region with calcifications. Our systematic analysis provides the most comprehensive insight into genetic, clinical, and neuroimaging features of known PFBC forms, to date. In addition, it puts forth the penetrance estimates and newly discovered genotype-phenotype relations that will improve counseling of individuals with mutations in PFBC genes. © 2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Keywords: JAM2; MYORG; PDGFB; PDGFRB; PFBC; SLC20A2; XPR1; primary familial brain calcification.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Yamada M, Asano T, Okamoto K, et al. High frequency of calcification in basal ganglia on brain computed tomography images in Japanese older adults. Geriatr Gerontol Int 2013;13:706-710.
    1. Nicolas G, Pottier C, Charbonnier C, et al. Phenotypic spectrum of probable and genetically-confirmed idiopathic basal ganglia calcification. Brain 2013;136:3395-3407.
    1. Baba Y, Broderick DF, Uitti RJ, Hutton ML, Wszolek ZK. Heredofamilial brain calcinosis syndrome. Mayo Clin Proc 2005;80:641-651.
    1. Scannapieco S, Picillo M, Del Gaudio L, Barone P, Erro R. A novel phenotype associated with CaSR-related familial brain calcifications. Mov Disord Clin Pract 2020;7:701-703.
    1. Westenberger A, Klein C. The genetics of primary familial brain calcifications. Curr Neurol Neurosci Rep 2014;14:490-499.

Publication types

Substances

LinkOut - more resources